版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
MULTIPLESCLEROSISMULTIPLESCLEROSISDEFINITIONOFMSItisdefinedclinicallybytheinvolvementofdifferentpartsoftheCNSatdifferenttimes-providedthatotherdisorderscausingmultifocalcentraldysfunctionhavebeenexcludedDEFINITIONOFMSItisdefinedEPIDEMIOLOGYInitialsymptomsgenerallycommencebeforetheageof55yearsoldwithapeakincidencebetweenages20and40.WomenareaffectednearlytwiceasoftenasmenEPIDEMIOLOGYInitialsymptomsgEPIDEMIOLOGYANDGENETICSIncidencerateinUnitedStates::30-60/100,000lessthan5/100,000inAsiaGeographicGradientsandincidenceratesEquator:lowLatitude40oNand40oSEPIDEMIOLOGYANDGENETICSIncidGENETICFACTORSINMSGeneticpredispositionissuggestedbytwinstudiesTwins:monozygotic30%dizygotic4%TheoccasionalfamilialincidenceandstrongassociationbetweenthediseaseandspecificHLAalleles(HLA-DRB*15:1,HLA-DB1*15:03)AllelsofIL2RAandIL7RAGENETICFACTORSINMSGeneticpPathologyDemyelinativelesionsarecommonlyincerebralhemisphere,opticnerve,spinalcord,brainstem,cerebellum.Periventricular–scatteredareasofdemyelinationfollowedbyareactivegliosis,theremaybeaxonaldamageaswellTheselesionoccurinthewhitematterofthebrainandcordandinoptic(II)nervePathologyDemyelinativelesionsPathophysiologyThecauseofMSisunknown,buttissuedamageandneurologicalsymptomsarethroughttobetriggeredbyanimmunemechanismdirectedagainstmyelinantigensViralinfectionorotherincitingfactorsmaypromotetheentryofTcellsandantibodiesintotheCNSbydisruptingtheblood–brainbarrierPathophysiologyThecauseofMSInitialorPresentingSymptoms&Signs:Commoninitialcomplaintsarefocalweakness,numbness,tingling,orunsteadinessinalimb,LhermittesignSuddenlossorblurringofvisioninoneeye(opticneuritis)Diplopia,internuclearophthalmoplegia,nystagmusDisequilibriumBladder-functiondisturbance(urinaryurgencyorhesitancy)suchsymptomsareoftentransient,disappearing
afterafewdaysorweekswithresidualdeficitCLINCALFEATURESOFMSInitialorPresentingSymptoms神经病学英文课件:07MULTIPLESCLEROSISOtherpatientspresentwithanacuteorgraduallyprogressivespasticparapresisandsensorydeficitSubsequentCourse:IntervalofmonthsoryearsaftertheinitialepisodebeforefurtherneurologicsymptomsappearNewsymptomsmaythendevelop,ororiginalonesmayrecurandprogress.Relapsesmaybetriggeredbyinfectionand,inwomen,aremorelikelyinthe3monthsorsofollowingchildbirthCLINCALFEATURESOFMSOtherpatientspresent神经病学英文课件:07MULTIPLESCLEROSISAriseinbodytemperaturecancausetransientdeteriorationinpatientwithafixedandstabledeficitWithtime-andafteranumberofrelapsesandusuallyincompleteremissions-thepatientmaybecomeincreasingdisabledbyweakness,stiffness,sensorydisturbances,unsteadinessofthelimbs,impairedvision,andurinaryincontinenceBasedonitscourse,thediseaseisdividedinto4majortypesCLINCALFEATURESOFMSAriseinbodytemperaturecanCLINICALSUBTYPESOFMS
Relapsingremitting(RR)ProgressiondoesnotoccurbetweenattacksPrimaryprogressive(PP)ThereisgradualprogressionofdisabilityfromclinicalonsetSecondaryprogressive(SP)AprogressivecourseafteraninitialRRpatternProgressiverelapsing(PR)CLINICALSUBTYPESOFMSRelapsMRIFINDINGSSUPPORTIVEOFMSDIAGNOSIS1GD-DTPAcontrastenhancelesionOR9noncontrastenhancehighsignallesionsonMRT2sequenceAtleast1periventricularlesionAtleast1infratentorial(Brainstemorcerebellar)lesionAtleast1juxtacorticallesionOvoidlesionsperpendicularOpenringonGadT1-weightedSpinalMRItor/ocongenitaloracquiredsurgicaltreatablelesionMRIFINDINGSSUPPORTIVEOFMS神经病学英文课件:07MULTIPLESCLEROSIS神经病学英文课件:07MULTIPLESCLEROSISCEREBROSPINALFLUIDINMSMildlymphocytosisNormalglucoseNormalormodestincreaseinproteinAbsentredbloodcellsIncreasedIgGIndex/SynthesisOligoclonalbands~90%CEREBROSPINALFLUIDINMSMild神经病学英文课件:07MULTIPLESCLEROSISLABTESTSMonocularvisualstimulationwithacheckerboardpattern(visualevokedpotentials,VEPs)Monauralstimulationwithrepetitiveclicks(brainstemauditoryevokedpotentials,BAEPs)Electricalstimulationofaperiphralnerve(somatosensoryevokedpotentials,SEPs)oneormoreabnorminMSLABTESTSMonocularvisualstim神经病学英文课件:07MULTIPLESCLEROSISSCHUMACHERCRITERIAFORMSOnsetatappropriateageCNSwhitematterdisease
DisseminatedintimeandspaceObjectiveabnormalitiesAttackslastingover24hoursonemonthapartGradualorstepwiseprogressionNoalternativediagnosisSCHUMACHERCRITERIAFORMSOnseDiagnosisCriteriaforMS
Poser(1983)
ClinicaldefiniteMS,CDMSLaboratory-supporteddefiniteMS,LSDMSClinicalprobableMS,CPMSLaboratory-supportedprobableMS,LSPMSDiagnosisCriteriaforMS
Pose2005Rev.McDonaldCriteria2005Rev.McDonaldCriteriaEDSSforMS
theExpandedDisabilityStatusScale
neurologicaltestingoffunctionalsystem1.Pyramidalfunction(abilitytowalk)2.Cerebellarfunction(coordination)3.BrainStem(speech&swallowing)4.Sensory(touch&pain)EDSSforMS
theExpandedDisabEDSSforMS
neurologicaltestingoffunctionalsystem5.Bowel&bladder6.Visual7.Mental8.OtherEDSSforMS
neurologicaltestiEDSSforMS
theExpandedDisabilityStatusScaleFrom0.0normalneurologicalexamto10.0-deathe.g.6.0intermittentorunilateralconstantassistance(cane,crutchorbrace)requiredtowalk100meterswithorwithoutrestinge.g.8.0essentiallyrestrictedtobed,chairorwheelchair,butmaybeoutofbedmuchofday;retainsselfcarefunctions,generallyeffectiveuseofarmsEDSSforMS
theExpandedDisabDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Neuromyelitisoptica:isarelapsingdisorder(formerlyknownasDevicdiseaseandonceconsideredavariantofMS)isassociatedwuthaspecificantibodymarker,NMO-IgG,thattargetsthewaterchannelaquaporin-4.ThefullyestablisheddisorderischararcterizedbyopticneuritisandacutemyelitisandassocitedwithMRIchangesthatextendoveratleast3segmentsofthespinalDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Usuallynobrainstem,cerebellar,orcerebraldemyelinativelesionandnormalityonMRIofwhitematter,absenceofOBbandandIgGinCSF,moreinAsiacountriesAcuteattacktreatedwithMPpusal,IVIG,PEwithlongtermimmnosuppressivetheraphyDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALOFMS-AcuteDisseminatedEncephalomyelitis(ADEM)Occursasasingleepisodeofneurologicalsymptomssandsignsdevelopedinfewdaysassociatedwithnonspecificviralinfectionorafterimmunization.CSFisnlorProteinincreased,GlucosenlMRIishelpfulinwhitematterlesionevenwithgraymatter.DIFFERENTIALOFMS-AcuteDisseIMMUNOPROPHYLACTIC
AGENTSFORRRMSINTERFERONINTERFERONbeta-1b(Betaseron)Subcutaneous,everyotherdayrecombinantprotein–Ecol,250µgINTERFERONbeta-1a(AVONEX)IM,weekly,recombinantprotein,30µgINTERFERONbeta1-a(REBIF)SQ3X/WEEK22OR44µgMayuseformorethan2yearsGlatirameracetate(Copaxone)Syntheticpolypeptide,subcut20mgdailyIMMUNOPROPHYLACTIC
AGENTSFORIMMUNOPROPHYLACTIC
AGENTSFORRRMSNatalizumab,analpha4integrinantibody,reducestherelapsingrate,butinrareunstancesisassociatedwithprogressivemultifocalleukoencephalopathyMethyl-predinisolone(1gdaily)3-5days,followedbyanoralprednisonetaper(80mg/dforaweek,withrapidreductionovertheensuing1-2weeks)Intravenousimmunoglobulin(IVIG)0.4g/kgfor5daysORPlasmapheresis(PE)IMMUNOPROPHYLACTIC
AGENTSFORTREATMENTOFFEREDFORSPANDPPMSCyclophosphamideAzathiopprine/methotrexateCladribine/cyclosporineMitoxantroneSteroidpulsewithhigh-doseIVMP1.0gonceamonthIFN-beta-1beffectiveTREATMENTOFFEREDFORSPANDTREATMENTOFACUTEEXACERBATIONSOFMSGlucocorticosteroidsHigh-dosei.v.methylprednisolone0.5to1.0g/dayvariablecombinationsPlasmaExchange
TREATMENTOFACUTEEXACERBATIOPROGNOSISAtleastpartialrecoveryfromanacuteepisodecanbeanticipated,butitisimpossibletopredictwhenthenextrelapsewilloccure.Morefavorableprognosis:female,onsetbefore40,andpresentationwithvisualorsomatosensory,ratherthanpyramidalorcellellardysfunction.About50%ofallpatientsareonlymildlyormoderatelydisabled10yearsaftertheonsetofsymptomsPROGNOSISAtleastpartialrecTHANKS!THANKS!MULTIPLESCLEROSISMULTIPLESCLEROSISDEFINITIONOFMSItisdefinedclinicallybytheinvolvementofdifferentpartsoftheCNSatdifferenttimes-providedthatotherdisorderscausingmultifocalcentraldysfunctionhavebeenexcludedDEFINITIONOFMSItisdefinedEPIDEMIOLOGYInitialsymptomsgenerallycommencebeforetheageof55yearsoldwithapeakincidencebetweenages20and40.WomenareaffectednearlytwiceasoftenasmenEPIDEMIOLOGYInitialsymptomsgEPIDEMIOLOGYANDGENETICSIncidencerateinUnitedStates::30-60/100,000lessthan5/100,000inAsiaGeographicGradientsandincidenceratesEquator:lowLatitude40oNand40oSEPIDEMIOLOGYANDGENETICSIncidGENETICFACTORSINMSGeneticpredispositionissuggestedbytwinstudiesTwins:monozygotic30%dizygotic4%TheoccasionalfamilialincidenceandstrongassociationbetweenthediseaseandspecificHLAalleles(HLA-DRB*15:1,HLA-DB1*15:03)AllelsofIL2RAandIL7RAGENETICFACTORSINMSGeneticpPathologyDemyelinativelesionsarecommonlyincerebralhemisphere,opticnerve,spinalcord,brainstem,cerebellum.Periventricular–scatteredareasofdemyelinationfollowedbyareactivegliosis,theremaybeaxonaldamageaswellTheselesionoccurinthewhitematterofthebrainandcordandinoptic(II)nervePathologyDemyelinativelesionsPathophysiologyThecauseofMSisunknown,buttissuedamageandneurologicalsymptomsarethroughttobetriggeredbyanimmunemechanismdirectedagainstmyelinantigensViralinfectionorotherincitingfactorsmaypromotetheentryofTcellsandantibodiesintotheCNSbydisruptingtheblood–brainbarrierPathophysiologyThecauseofMSInitialorPresentingSymptoms&Signs:Commoninitialcomplaintsarefocalweakness,numbness,tingling,orunsteadinessinalimb,LhermittesignSuddenlossorblurringofvisioninoneeye(opticneuritis)Diplopia,internuclearophthalmoplegia,nystagmusDisequilibriumBladder-functiondisturbance(urinaryurgencyorhesitancy)suchsymptomsareoftentransient,disappearing
afterafewdaysorweekswithresidualdeficitCLINCALFEATURESOFMSInitialorPresentingSymptoms神经病学英文课件:07MULTIPLESCLEROSISOtherpatientspresentwithanacuteorgraduallyprogressivespasticparapresisandsensorydeficitSubsequentCourse:IntervalofmonthsoryearsaftertheinitialepisodebeforefurtherneurologicsymptomsappearNewsymptomsmaythendevelop,ororiginalonesmayrecurandprogress.Relapsesmaybetriggeredbyinfectionand,inwomen,aremorelikelyinthe3monthsorsofollowingchildbirthCLINCALFEATURESOFMSOtherpatientspresent神经病学英文课件:07MULTIPLESCLEROSISAriseinbodytemperaturecancausetransientdeteriorationinpatientwithafixedandstabledeficitWithtime-andafteranumberofrelapsesandusuallyincompleteremissions-thepatientmaybecomeincreasingdisabledbyweakness,stiffness,sensorydisturbances,unsteadinessofthelimbs,impairedvision,andurinaryincontinenceBasedonitscourse,thediseaseisdividedinto4majortypesCLINCALFEATURESOFMSAriseinbodytemperaturecanCLINICALSUBTYPESOFMS
Relapsingremitting(RR)ProgressiondoesnotoccurbetweenattacksPrimaryprogressive(PP)ThereisgradualprogressionofdisabilityfromclinicalonsetSecondaryprogressive(SP)AprogressivecourseafteraninitialRRpatternProgressiverelapsing(PR)CLINICALSUBTYPESOFMSRelapsMRIFINDINGSSUPPORTIVEOFMSDIAGNOSIS1GD-DTPAcontrastenhancelesionOR9noncontrastenhancehighsignallesionsonMRT2sequenceAtleast1periventricularlesionAtleast1infratentorial(Brainstemorcerebellar)lesionAtleast1juxtacorticallesionOvoidlesionsperpendicularOpenringonGadT1-weightedSpinalMRItor/ocongenitaloracquiredsurgicaltreatablelesionMRIFINDINGSSUPPORTIVEOFMS神经病学英文课件:07MULTIPLESCLEROSIS神经病学英文课件:07MULTIPLESCLEROSISCEREBROSPINALFLUIDINMSMildlymphocytosisNormalglucoseNormalormodestincreaseinproteinAbsentredbloodcellsIncreasedIgGIndex/SynthesisOligoclonalbands~90%CEREBROSPINALFLUIDINMSMild神经病学英文课件:07MULTIPLESCLEROSISLABTESTSMonocularvisualstimulationwithacheckerboardpattern(visualevokedpotentials,VEPs)Monauralstimulationwithrepetitiveclicks(brainstemauditoryevokedpotentials,BAEPs)Electricalstimulationofaperiphralnerve(somatosensoryevokedpotentials,SEPs)oneormoreabnorminMSLABTESTSMonocularvisualstim神经病学英文课件:07MULTIPLESCLEROSISSCHUMACHERCRITERIAFORMSOnsetatappropriateageCNSwhitematterdisease
DisseminatedintimeandspaceObjectiveabnormalitiesAttackslastingover24hoursonemonthapartGradualorstepwiseprogressionNoalternativediagnosisSCHUMACHERCRITERIAFORMSOnseDiagnosisCriteriaforMS
Poser(1983)
ClinicaldefiniteMS,CDMSLaboratory-supporteddefiniteMS,LSDMSClinicalprobableMS,CPMSLaboratory-supportedprobableMS,LSPMSDiagnosisCriteriaforMS
Pose2005Rev.McDonaldCriteria2005Rev.McDonaldCriteriaEDSSforMS
theExpandedDisabilityStatusScale
neurologicaltestingoffunctionalsystem1.Pyramidalfunction(abilitytowalk)2.Cerebellarfunction(coordination)3.BrainStem(speech&swallowing)4.Sensory(touch&pain)EDSSforMS
theExpandedDisabEDSSforMS
neurologicaltestingoffunctionalsystem5.Bowel&bladder6.Visual7.Mental8.OtherEDSSforMS
neurologicaltestiEDSSforMS
theExpandedDisabilityStatusScaleFrom0.0normalneurologicalexamto10.0-deathe.g.6.0intermittentorunilateralconstantassistance(cane,crutchorbrace)requiredtowalk100meterswithorwithoutrestinge.g.8.0essentiallyrestrictedtobed,chairorwheelchair,butmaybeoutofbedmuchofday;retainsselfcarefunctions,generallyeffectiveuseofarmsEDSSforMS
theExpandedDisabDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Neuromyelitisoptica:isarelapsingdisorder(formerlyknownasDevicdiseaseandonceconsideredavariantofMS)isassociatedwuthaspecificantibodymarker,NMO-IgG,thattargetsthewaterchannelaquaporin-4.ThefullyestablisheddisorderischararcterizedbyopticneuritisandacutemyelitisandassocitedwithMRIchangesthatextendoveratleast3segmentsofthespinalDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Usuallynobrainstem,cerebellar,orcerebraldemyelinativelesionandnormalityonMRIofwhitematter,absenceofOBbandandIgGinCSF,moreinAsiacountriesAcuteattacktreatedwithMPpusal,IVIG,PEwithlongtermimmnosuppressivetheraphyDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALOFMS-AcuteDisseminatedEncephalomyelitis(ADEM)Occursasasingleepisodeofneurologicalsymptomssandsignsdevelopedinfewdaysassociatedwithnonspecificviralinfectionorafterimmunization.CSFisnlorProteinincreased,GlucosenlMRIishelpfulinwhitematterlesionevenwithgraymatter.DIFFERENTIALOF
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 生活护理课件与学习资料
- Unit4 Reading and Thinking课件2025-2026学年高中英语人教版必修第三册
- 积滞患者护理皮肤护理
- 2020-2021年人教版五年级语文上册期中考试题(学生专用)
- 护工安全意识培养:护理安全实践
- 申请公积金贷款购买二手房除首付外还需准备的过户税费及中介费清单
- DB31-T 748-2026 水电气计量差错的退补量核算方法
- 2026届广东汕头市普通高考第一次模拟考试英语试题
- 特殊药物使用的安全监控
- 白内障手术患者术前心理支持护理
- (高清版)DZT 0291-2015 饰面石材矿产地质勘查规范
- 人工智能行业的智能市场与智能客户关系管理技术培训
- 塑造非权力影响力
- 老师我们的朋友
- 大学生志愿服务西部计划考试复习题库(笔试、面试题)
- 杭州西溪国家湿地公园总体规划修编 文本
- 材料的力学行为
- GB/T 42415-2023表面活性剂静态表面张力的测定
- YY/T 1681-2019医疗器械唯一标识系统基础术语
- GB/T 25380-2010数控滚齿机精度检验
- plm实施工具11培训课件库cmii培训课件
评论
0/150
提交评论